Genopathy
Gene-Disorder Association · Article
Gene
MET
MET Proto-Oncogene, Receptor Tyrosine Kinase
First reported 1976
Supporting publications 1
Manually curated
Association Review

In brief

The association between MET (MET Proto-Oncogene, Receptor Tyrosine Kinase) and Papillary Renal Cell Carcinoma is a manually-curated gene–disease association, with its 2 contributing sources — 1 of them expert-curated — recording causative variation.

Sources 2
Clinical variants 1
Symptoms 1
Compounds 0
Trials 0
Publications 1
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

2 sources

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
MET

The gene

3 source summaries

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Papillary Renal Cell Carcinoma

The disorder

14 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
ClinVar and variant evidence

Genetic basis

1 clinical variant

ClinVar variants reported for this pair, with disorder-specific significance, review status, molecular consequence and origin.

Request access
06
Mechanism overlap

Shared mechanisms

1 shared pathway

Biological pathways and phenotype concepts shared by the gene and the disorder, with supporting publications.

Request access
07
Literature

Reading

1 publication

Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.

Request access
08
Provenance

References & sources

13 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access